Inotuzumab ozogamicin Intravenous and Insulin degludec and liraglutide
Determining the interaction of Inotuzumab ozogamicin Intravenous and Insulin degludec and liraglutide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin Degludec and Liraglutide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Insulin degludec and liraglutide Subcutaneous
- Inotuzumab ozogamicin Intravenous-Insulin degludec Subcutaneous
- Inotuzumab ozogamicin Intravenous-Insulin detemir
- Inotuzumab ozogamicin Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Inotuzumab ozogamicin Intravenous-Insulin Detemir (Vials)
- Inotuzumab ozogamicin Intravenous-Insulin detemir Subcutaneous
- Insulin degludec and liraglutide-Inova
- Insulin degludec and liraglutide-Inova 4/1 topical
- Insulin degludec and liraglutide-Inova 8/2 topical
- Insulin degludec and liraglutide-Inova ACT
- Insulin degludec and liraglutide-Inrebic
- Insulin degludec and liraglutide-Inspra